(Q44366883)

2 December 2017

title

Sir David Cuthbertson Medal Lecture. Bariatric surgery as a model to study appetite control (English)

1 reference

2 December 2017

1 reference

2

1 reference

2 December 2017

1

Marco Bueter

1 reference

2 December 2017

publication date

29 April 2009

1 reference

Proceedings of the Nutrition Society

2 December 2017

published in

1 reference

2 December 2017

volume

68

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

227-233

1 reference

A role for glucagon-like peptide-1 in the central regulation of feeding

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

On the physiology of GIP and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Food fails to suppress ghrelin levels in obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Treatment of cachexia with ghrelin in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Ghrelin causes hyperphagia and obesity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Is gastrin partially responsible for body weight reduction after gastric bypass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Changes in Energy Expenditure Resulting from Altered Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Does ghrelin really matter after bariatric surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Is the energy homeostasis system inherently biased toward weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Obesity wars: molecular progress confronts an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Ghrelin enhances appetite and increases food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Healthcare utilization and outcomes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Incidence of deep venous thrombosis in patients undergoing obesity surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Explanations for weight loss after ileojejunal bypass in gross obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Meta-analysis: surgical treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effect of peptide YY3-36 on food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Weight loss and plasma ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Obesity and pharmacologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Pharmacological therapies for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

The public health impact of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Exenatide: its position in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effect of GLP-1 on lipid metabolism in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Rapid development of tolerance to the behavioural actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Does gut hormone PYY3–36 decrease food intake in rodents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

Effects of peptide YY and neuropeptide Y on gastric emptying in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Obesity in North America. An overview

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

https://api.crossref.org/works/10.1017%2FS0029665109001256

1 reference

7 January 2021

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Peptide YY abnormalities in gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Morbid obesity--surgical treatment--when and how?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Lipolytic action of glucagon-like peptides in isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

A role for central glucagon-like peptide-1 in temperature regulation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Ghrelin increases food intake in obese as well as lean subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665109001256

7 January 2021

10.1017/S0029665109001256

Identifiers

DOI

1 reference

2 December 2017

1 reference